Prevalence of Chronic Non-Communicable Respiratory Diseases in Mosul City
https://doi.org/10.47836/mjmhs.20.1.27
- Author:
Radhwan Hussein Ibrahim
1
;
Ahmed Abdulrazzaq Malallah Al-Nuaimy
1
Author Information
1. Department of Clinical Nursing Sciences, College of Nursing, Ninevah University, Mosul, Iraq
- Publication Type:Journal Article
- Keywords:
Chronic non-communicable respiratory diseases, bronchial asthma, prevalence, risk factors, epidemiological study
- From:Malaysian Journal of Medicine and Health Sciences
2024;20(No.1):205-211
- CountryMalaysia
- Language:English
-
Abstract:
Introduction: Chronic non-communicable respiratory diseases (CNCRDs) encompass a group of conditions affecting
the airways and lung structures, including Chronic Obstructive Pulmonary Disease (COPD), emphysema, allergic
rhinitis, asthma, pulmonary arterial hypertension, and cystic fibrosis. CNCRDs pose a significant global health challenge, resulting in approximately four million deaths annually. This study aimed to identify the prevalence and risk
factors associated with CNCRDs and measure trends in the prevalence of these risk factors over time. Methods: A
cross-sectional epidemiological study was conducted using data collected from primary health centers on both sides
of Mosul City. The study period extended from January 1 to July 31, 2022, with information obtained from (40) primary health centers, consisting of (20) centers on the right side and (20) centers on the left side of Mosul. Results:
In 2021, the City of Mosul recorded a total of 13,005 registered cases, with 5,598 cases being attributed to asthma
(43%), and 7,347 cases being associated with COPD (57%). Bronchial asthma constituted 43% of cases, with 5598
patients, and the highest incidence occurred in the age group between 20-44 years. Conclusion: The prevalence
of bronchial asthma and COPD among patients with CNCRDs in Mosul is alarmingly high. It emphasizes the importance of implementing preventive policies and strategies targeting modifiable risk factors for these respiratory
conditions.
- Full text:11.2024my1731.pdf
